dc.date.accessioned2021-08-23T22:52:38Z
dc.date.accessioned2022-10-19T00:20:03Z
dc.date.available2021-08-23T22:52:38Z
dc.date.available2022-10-19T00:20:03Z
dc.date.created2021-08-23T22:52:38Z
dc.date.issued2015
dc.identifierhttp://hdl.handle.net/10533/251009
dc.identifier1150901
dc.identifierWOS:000356112900020
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4482272
dc.description.abstractAdjuvants used in vaccine aquaculture are frequently harmful for the fish, causing melanosis, granulomas and kidney damage. Along with that, vaccines are mostly administered by injection, causing pain and stress to the fish. We used the DNA coding for the replicase of alphavirus as adjuvant (Ad) of a vaccine against ISAV. The Ad and an inactivated ISAV (V) were loaded in chitosan nanoparticles (NPs) to be administered orally to Atlantic salmon. NP-Ad was able to deliver the DNA ex vivo and in vivo. Oral administration of the NPs stimulated the expression of immune molecules, but did not stimulate the humoral response. Although the vaccination with NP-V results in a modest protection of fish against ISAV, NP-V administered together with NP-Ad caused a protection of 77%. Therefore, the DNA coding for the replicase of alphavirus could be administered orally and can potentiate the immuneprotection of a virine against infection. (C) 2015 Elsevier Ltd. All rights reserved.
dc.languageeng
dc.relationhttps://doi.org/10.1016/j.fsi.2015.03.033
dc.relationhandle/10533/111557
dc.relation10.1016/j.fsi.2015.03.033
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.rightsinfo:eu-repo/semantics/article
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titleDevelopment of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant
dc.typeArticulo


Este ítem pertenece a la siguiente institución